Literature DB >> 14692562

HnRNP A2/B1 proteins in nontumorous alveolar cells.

H Satoh1, H Ishikawa, H Kamma, Y T Yamashita, K Sekizawa.   

Abstract

The overexpression of heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1, especially of B1, had been reported to detect preclinical lung cancer for early detection. In order to examine whether the expression of the protein is specific for lung cancer, we investigated the expression of the protein in human nonmalignant alveolar cells. Human airway cells obtained by bronchoalveolar lavage (BAL) were analyzed by immunostaining and Western blotting using monoclonal antibodies 4G8 (specifically reacts to A2) and 2B2 (specific to B1). In alveolar cells obtained by BAL, hnRNP A2/B1 proteins were localized primarily in the nucleus, excluding the nucleolus, although the expression of A2 protein was weaker than that of B1 protein. Staining pattern of these cells was similar to those observed in cancer cells. Western blotting with 4G8 and 2B2 demonstrated expression of A2 and B1 proteins in the airway cells. HnRNP A2/B1 proteins were apparently expressed in nonmalignant alveolar cells as well as cancer cells, although the expression in alveolar cells was weaker than that of cancer cells. More quantitative determination of A2/B1 is required to elucidate their significance in early lung cancer detection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14692562     DOI: 10.1007/s00408-003-1024-z

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  18 in total

1.  hnRNP B1 expression in benign and malignant lung disease.

Authors:  D R J Snead; B Perunovic; N Cullen; M Needham; D P Dhillon; H Satoh; H Kamma
Journal:  J Pathol       Date:  2003-05       Impact factor: 7.996

2.  Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection.

Authors:  P Fielding; L Turnbull; W Prime; M Walshaw; J K Field
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

3.  Characterization of heterogeneous nuclear RNA-protein complexes in vivo with monoclonal antibodies.

Authors:  G Dreyfuss; Y D Choi; S A Adam
Journal:  Mol Cell Biol       Date:  1984-06       Impact factor: 4.272

4.  Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.

Authors:  E Sueoka; Y Goto; N Sueoka; Y Kai; T Kozu; H Fujiki
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

5.  Characterization of hnRNP A2 and B1 using monoclonal antibodies: intracellular distribution and metabolism through cell cycle.

Authors:  H Kamma; H Satoh; M Matusi; W W Wu; M Fujiwara; H Horiguchi
Journal:  Immunol Lett       Date:  2001-02-01       Impact factor: 3.685

6.  Expression of hnRNP A2/B1 proteins in human cancer cell lines.

Authors:  H Satoh; H Kamma; H Ishikawa; H Horiguchi; M Fujiwara; Y T Yamashita; M Ohtsuka; K Sekizawa
Journal:  Int J Oncol       Date:  2000-04       Impact factor: 5.650

Review 7.  [The concept, definition and diagnostic criteria of sarcoidosis].

Authors:  M Yamamoto
Journal:  Nihon Rinsho       Date:  1994-06

8.  Expression of heterogeneous nuclear ribonucleoprotein A2/B1 changes with critical stages of mammalian lung development.

Authors:  L M Montuenga; J Zhou; I Avis; M Vos; A Martinez; F Cuttitta; A M Treston; M Sunday; J L Mulshine
Journal:  Am J Respir Cell Mol Biol       Date:  1998-10       Impact factor: 6.914

9.  Purification and characterization of a protein that permits early detection of lung cancer. Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4.

Authors:  J Zhou; J L Mulshine; E J Unsworth; F M Scott; I M Avis; M D Vos; A M Treston
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

10.  Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma.

Authors:  Y Goto; E Sueoka; H Chiba; H Fujiki
Journal:  Jpn J Cancer Res       Date:  1999-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.